Please login to the form below

Not currently logged in
Email:
Password:

FCB Health’s Neon attracts new managing director

Mardene Miller will lead the agency with co-managing director Kevin McHale

Mardene Miller

Neon has named Harrison and Star's former president Mardene Miller (pictured above) as its new co-managing director.

Neon, which is located in New York, US, is a full-service agency specialising in multichannel marketing, strategic planning and health literacy.

It has a workforce of around 175 employees and operates under the FCB Health Network umbrella.

Miller will lead the 175-workforce agency alongside Kevin McHale, who is also the creative chief.

He said: “Neon is continuing its upward trajectory into 2019. With this redoubled focus in executive management and our commitment to creativity there is no doubt that we will continue to enjoy double digit growth and continue to offer our full service expertise to all brands in need of strategic, creative and account excellence.”

Neon has most recently secured an account win with ColoGuard, a co-promotion initative with Exact Sciences and Pfizer.

In addition, 2018 saw an influx of several new business wins for the agency, which included AbbVie and Flexion.

Regarding her new role at Neon, Miller said: “I am excited to join this exceptional Network, which is setting the bar for creativity and is spearheaded by such a dynamic leader in Dana Maiman.”

Article by
Gemma Jones

14th February 2019

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....